NCT04998422 - A Study of HG381 Administered to Patients With Advanced Solid Tumors | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 18, 2021

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions

Advanced Solid Tumor

Interventions

DRUG

HG381

HG381 is available as white to off-white cake or powder for solution for injection at a unit dose strength of 5 mg per vial. HG381 will be administered as IV injection.

Trial Locations (1)

610200

RECRUITING

HitGen Inc., Chengdu